Literature DB >> 6096403

Cobalamin and folate binding proteins in human tumour tissue.

K Sheppard, D A Bradbury, J M Davies, D R Ryrie.   

Abstract

The serum of an 84 year old man with disseminated carcinoma was found to contain extremely high concentrations of cobalamin and of a cobalamin binding protein with trans-cobalamin I characteristics. Tumour tissue samples obtained at necropsy contained considerably higher concentrations of cobalamin binding protein (R-binder) than normal tissues. Tumour tissues also contained increased concentrations of specific folate binding protein. In all tissues studied a close correlation existed between unsaturated cobalamin and unsaturated folate binding and between total cobalamin and total folate binding. These results suggest related mechanisms for the synthesis of cobalamin binding proteins of the R-binder class and folate binding proteins by tumour tissue.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096403      PMCID: PMC499010          DOI: 10.1136/jcp.37.12.1336

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  22 in total

1.  Characterization of R-type vitamin B12-binding proteins by isoelectric focusing. II. Comparison of cobalophilin (r proteins) from different sources.

Authors:  U H Stenman
Journal:  Scand J Clin Lab Invest       Date:  1975-03       Impact factor: 1.713

2.  Extreme elevation of serum transcobalamin I in patients with metastatic cancer.

Authors:  R Carmel
Journal:  N Engl J Med       Date:  1975-02-06       Impact factor: 91.245

3.  Serum vitamin B12 and transcobalamin abnormalities in patients with cancer.

Authors:  R Carmel; L Eisenberg
Journal:  Cancer       Date:  1977-09       Impact factor: 6.860

4.  The synthesis of transcobalamin II, a vitamin B12 transport protein, by stimulated mouse peritoneal macrophages.

Authors:  B Rachmilewitz; M Rachmilewitz; M Chaouat; M Schlesinger
Journal:  Biomedicine       Date:  1977-07

5.  A simplified method of quantitating protein using the biuret and phenol reagents.

Authors:  S T Ohnishi; J K Barr
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

6.  Characterization of R-type vitamin B12-binding proteins by isoelectric focusing. I. The relationship between transcobalamin I, transcobalamin III and the granulocyte R protein.

Authors:  U H Stenman
Journal:  Scand J Haematol       Date:  1974

7.  Identification of a new vitamin B 12 binder (transcobalamin 3) in normal human serum.

Authors:  F J Bloomfield; J M Scott
Journal:  Br J Haematol       Date:  1972-01       Impact factor: 6.998

8.  Vitamin B12-binders in human body fluids. I. Antigenic and physico-chemical characteristics.

Authors:  J Hurlimann; C Zuber
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

9.  Analytical subcellular fractionation of human granulocytes with reference to the localization of vitamin B12-binding proteins.

Authors:  S P Kane; T J Peters
Journal:  Clin Sci Mol Med       Date:  1975-08

10.  Measurement of serum folate levels and serum folic acid-binding protein by 3H-PGA radioassay.

Authors:  S Waxman; C Schreiber
Journal:  Blood       Date:  1973-08       Impact factor: 22.113

View more
  5 in total

1.  Synthesis and secretion of a cobalamin-binding protein by HT 29 cell line.

Authors:  H Schohn; J L Guéant; M Girr; E Nexø; L Baricault; A Zweibaum; J P Nicolas
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

Review 2.  Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.

Authors:  Valentin Lacombe; Guy Lenaers; Geoffrey Urbanski
Journal:  Nutrients       Date:  2022-05-14       Impact factor: 6.706

3.  Distribution of vitamin B12 R-binder in carcinomas of the digestive tract.

Authors:  H Kudo; G Ohshio; K Ogawa; Y C Kim; Y Wakatsuki; Y Nakashima; H Yamabe; M Inada
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

4.  Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.

Authors:  Yi-Ying Lee; Yu-Ching Wei; Yu-Feng Tian; Ding-Ping Sun; Ming-Jen Sheu; Ching-Chieh Yang; Li-Ching Lin; Chen-Yi Lin; Chung-Hsi Hsing; Wan-Shan Li; Chien-Feng Li; Pei-Ling Hsieh; Ching-Yih Lin
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207

5.  Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers.

Authors:  Ying Wang; Changli Yue; Jugao Fang; Lili Gong; Meng Lian; Ru Wang; Ling Feng; Hongzhi Ma; Zhihong Ma; Honggang Liu
Journal:  Onco Targets Ther       Date:  2018-07-24       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.